Covered recipient · General Payments record
ARUNA AREKAPUDI
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$4,684.36
- Reported across 236 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.04 | 14 |
| Education | $176.14 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $240.04 | 5 |
| E.R. Squibb & Sons, L.L.C. | $57.14 | 3 |
| Celgene Corporation | $54.64 | 2 |
| PFIZER INC. | $41.17 | 2 |
| ADC Therapeutics America, Inc. | $21.86 | 1 |
| Pharmacosmos Therapeutics Inc. | $20.10 | 1 |
| Daiichi Sankyo Inc. | $17.62 | 1 |
| Astellas Pharma US Inc | $15.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics America, Inc. | $21.86 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121191051 | CMS |
| Astellas Pharma US Inc | $15.61 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139383546 | CMS |
| Celgene Corporation | $25.83 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101179310 | CMS |
| Celgene Corporation | $28.81 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101179316 | CMS |
| Daiichi Sankyo Inc. | $17.62 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089394274 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.59 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101733875 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.16 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101733897 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.39 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101733926 | CMS |
| Lilly USA, LLC | $23.50 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136050439 | CMS |
| Lilly USA, LLC | $21.83 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136055146 | CMS |
| Lilly USA, LLC | $92.34 | 06/07/2024 | Education | Undisputed | 01/23/2026 | 1136000857 | CMS |
| Lilly USA, LLC | $83.80 | 06/07/2024 | Education | Undisputed | 01/23/2026 | 1136054102 | CMS |
| Lilly USA, LLC | $18.57 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136050437 | CMS |
| PFIZER INC. | $21.71 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132049446 | CMS |
| PFIZER INC. | $19.46 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132084828 | CMS |
| Pharmacosmos Therapeutics Inc. | $20.10 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154819735 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.